Percutaneous exposure to the nerve agent VX: Efficacy of combined atropine, obidoxime and diazepam treatment

Chemico-Biological Interactions

Volumn 188, Issue 1, 2010, Pages 255-263

  Joosen, Marloes J A ^a   van der Schans, Marcel J ^a   van Helden, Herman P M ^a  

^a TNO   (Netherlands)

Author keywords

EEG; Organophosphate; Percutaneous; Physiology; Treatment; VX

Indexed keywords

ACETYLCHOLINESTERASE; ATROPINE; CHOLINESTERASE; DIAZEPAM; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; OBIDOXIME; ANTIDOTE; CHEMICAL WARFARE AGENT; PHOSPHOROTHIOIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREATHING RATE; BRONCHOSPASM; CONTROLLED STUDY; DETERIORATION; DRUG BLOOD LEVEL; DRUG EFFICACY; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; ENZYME BLOOD LEVEL; ENZYME INHIBITION; EXPOSURE; GUINEA PIG; HEART RATE; INTOXICATION; LUNG MINUTE VOLUME; MALE; NONHUMAN; SINGLE DRUG DOSE; SKIN ABSORPTION; SKIN DECONTAMINATION; SKIN PENETRATION; TOXICOKINETICS; ANIMAL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN; TOXICITY;

ANIMALS; ANTIDOTES; ATROPINE; CHEMICAL WARFARE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIAZEPAM; GUINEA PIGS; OBIDOXIME CHLORIDE; ORGANOTHIOPHOSPHORUS COMPOUNDS; SKIN;

CAVIA;

EID: 77956172546     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.06.010     Document Type: Article

References (21)

1. van der Schans M.J., Lander B.J., van der W.H., Langenberg J.P., Benschop H.P. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 2003, 191:48-62.
2. Chemical Warfare Agents, Chemistry, Pharmacology, Toxicology, and Therapeutics Romano, J.A., Jr., Lukey, B.J., Salem, H., (Eds.). Boca Raton, USA: CRC Press.
3. Joosen M.J., van der Schans M.J., van Helden H.P. Percutaneous exposure to VX: clinical signs, effects on brain acetylcholine levels and EEG. Neurochem. Res. 2008, 33:308-317.
4. Wetherell J., Price M., Mumford H., Armstrong S., Scott L. Development of next generation medical countermeasures to nerve agent poisoning. Toxicology 2007, 233:120-127.
5. Dalton C.H., Hattersley I.J., Rutter S.J., Chilcott R.P. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. Toxicol. In Vitro 2006, 20:1532-1536.
6. Hamilton M.G., Hill I., Conley J., Sawyer T.W., Caneva D.C., Lundy P.M. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: effects of application site and decontamination. Mil. Med. 2004, 169:856-862.
7. Frasch H.F., Barbero A.M. A paired comparison between human skin and hairless guinea pig skin in vitro permeability and lag time measurements for 6 industrial chemicals. Cutan. Ocul. Toxicol. 2009, 28:107-113.
8. Maynard R.L., Beswick F.E. Organophosphorous compounds as chemical warfare agents 1992, 373-385.
9. Worek F., Reiter G., Eyer P., Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch. Toxicol. 2002, 76:523-529.
10. Shih T.M., Rowland T.C., McDonough J.H. Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine. J. Pharmacol. Exp. Ther. 2007, 320:154-161.
11. Bosgra S., van Eijkeren J.C., van der Schans M.J., Langenberg J.P., Slob W. Toxicodynamic analysis of the combined cholinesterase inhibition by paraoxon and methamidophos in human whole blood. Toxicol. Appl. Pharmacol. 2009, 236:9-15.
12. Hilmas C.J., Poole M.J., Finneran K., Clark M.G., Williams P.T. Galantamine is a novel post-exposure therapeutic against lethal VX challenge. Toxicol. Appl. Pharmacol. 2009.
13. F.R. Sidel, E.T. Takafuji, D.R. Franz. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Washington DC: Office of the Surgeon General.
14. Epstein J., Callahan J.J., Bauer V.E. Kinetics and mechanisms of hydrolysis of phosphonothiolates in dilute solution. Phosphorus 1974, 4:157-163.
15. Maxwell D.M., Brecht K.M., Koplovitz I. Characterization and treatment of the toxicity of O-isobutyl S-(2-(diethylamino)ethyl)methylphosphothionate, a structural isomer of VX, in guinea pigs. J. Am. Coll. Toxicol. 1997, S78-S88.
16. Rocha E.S., Santos M.D., Chebabo S.R., Aracava Y., Albuquerque E.X. Low concentrations of the organophosphate VX affect spontaneous and evoked transmitter release from hippocampal neurons: toxicological relevance of cholinesterase-independent actions. Toxicol. Appl. Pharmacol. 1999, 159:31-40.
17. Chang F.C., Gouty S.C., Eder L.C., Hoffman B.E., Maxwell D.M., Brecht K.M. Cardiorespiratory effects of O-isobutyl S-[2-(diethylamino)-ethyl] methylphosphonothioate - a structural isomer of VX. J. Appl. Toxicol. 1998, 18:337-347.
18. Cohen R.A., Hasegawa Y., Fisher M. Effects of a novel NMDA receptor antagonist on experimental stroke quantitatively assessed by spectral EEG and infarct volume. Neurol. Res. 1994, 16:443-448.
19. Thiermann H., Worek F., Eyer P., Eyer F., Felgenhauer N., Zilker T. Obidoxime in acute organophosphate poisoning: 2 - PK/PD relationships. Clin. Toxicol. (Phila) 2009, 47:807-813.
20. Lallement G., Carpentier P., Collet A., Baubichon D., Pernot-Marino I., Blanchet G. Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology 1992, 13:557-567.
21. Joosen M.J., Jousma E., van den Boom T.M., Kuijpers W.C., Smit A.B., Lucassen P.J., van Helden H.P. Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning. Neurotoxicology 2009, 30:72-80.